European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma ...

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.

The researchers also obtained nasopharyngeal aspirate samples from children with lung symptoms for 3 consecutive days to identify causative pathogens. Quasi-Poisson regression models were used for ...

The researchers also obtained nasopharyngeal aspirate samples from children with lung symptoms for 3 consecutive days to identify causative pathogens.

Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal carcinoma, new data suggest.

Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial. If you have the appropriate software installed, you can ...